Google Scholar Metrics

Earlier this month, Google Scholar released the 2018 Scholar Metrics. It covers articles from 2013-2017 and those indexed as of July 2018. Metrics include journal articles from websites and select conference papers from Computer Science & Electrical Engineering.  Users may also browse by categories like Public Health and Food Science and Technology.

You may access Google from the MSK Library’s Databases A-Z list.  Additionally, if you are new to Google Scholar, please feel free to ASK US.

Do “Zombie” Genes Help Fend Off Cancer in Elephants?

A new study led by researchers at the University of Chicago offers insight on how a “zombie” gene plays a key role in protecting elephants and other large animals from developing cancer. “Peto’s Paradox”, the lack of correlation between body size and cancer risk has intrigued and confounded cancer researchers for decades. In basic terms, big animals (think elephants, blue whales) should equal more cancer, simply because their bodies contain more cells and undergo more cell divisions.



Slower metabolic rates and slower growing tumors may play a role, but the University of Chicago researchers point to another factor – extra “zombie” LIF genes, including LIF6 (a leukemia inhibiting factor pseudogene), which is up-regulated by the master tumor suppressor gene p53 in response to DNA damage. When activated by p53 these “zombie” genes respond to damaged DNA by killing the cell.

MSK Researcher Questions Gene Editing Claims

CRISPR is a promising gene editing tool being studied in laboratories worldwide as an inexpensive and precise mechanism for targetting specific genetic mutations. It could one day translate into treatments for genetic diseases in humans.

Last year, biologists from Oregon Health & Science University, led by Dr. Shoukhrat Mitalipov, published a study in Nature claiming they used CRISPR to fix a heart-disease-causing mutation in fertilized human embryos. Many scientists, including MSK’s Dr. Maria Jasin, questioned the plausibility of the findings.

Last week, the study hit the news again. Nature published a rebuttal to the criticism by Dr. Mitalipov and colleagues, along with two critiques, including one co-authored by Dr. Jasin.

Read coverage of the updated study and critiques:
MIT Technology Review
Nature News and Comment
Science News
The Scientist
Stat News
Wired

Learn more about CRISPR:
Genetics Home Reference
National Cancer Institute
Science News for Students